[go: up one dir, main page]

AU2003297570A1 - Treatment of skin diseases - Google Patents

Treatment of skin diseases

Info

Publication number
AU2003297570A1
AU2003297570A1 AU2003297570A AU2003297570A AU2003297570A1 AU 2003297570 A1 AU2003297570 A1 AU 2003297570A1 AU 2003297570 A AU2003297570 A AU 2003297570A AU 2003297570 A AU2003297570 A AU 2003297570A AU 2003297570 A1 AU2003297570 A1 AU 2003297570A1
Authority
AU
Australia
Prior art keywords
treatment
skin diseases
diseases
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003297570A
Inventor
Boris Skurkovich
Simon Skurkovich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Biotherapy Concepts Inc
Original Assignee
Advanced Biotherapy Concepts Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/305,210 external-priority patent/US20030223995A1/en
Priority claimed from US10/304,802 external-priority patent/US20030228310A1/en
Application filed by Advanced Biotherapy Concepts Inc filed Critical Advanced Biotherapy Concepts Inc
Publication of AU2003297570A1 publication Critical patent/AU2003297570A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2003297570A 2002-11-26 2003-11-26 Treatment of skin diseases Abandoned AU2003297570A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10/305,210 2002-11-26
US10/305,210 US20030223995A1 (en) 1996-12-23 2002-11-26 Treatment of pemphigus vulgaris
US10/304,802 2002-11-26
US10/304,802 US20030228310A1 (en) 1996-12-23 2002-11-26 Treatment of skin diseases
PCT/US2003/037892 WO2004047864A1 (en) 2002-11-26 2003-11-26 Treatment of skin diseases

Publications (1)

Publication Number Publication Date
AU2003297570A1 true AU2003297570A1 (en) 2004-06-18

Family

ID=32396717

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003297570A Abandoned AU2003297570A1 (en) 2002-11-26 2003-11-26 Treatment of skin diseases

Country Status (2)

Country Link
AU (1) AU2003297570A1 (en)
WO (1) WO2004047864A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2337799A2 (en) * 2008-08-28 2011-06-29 Wyeth LLC Uses of il-22, il-17, and il-1 family cytokines in autoimmune diseases
US20250320288A1 (en) * 2022-06-02 2025-10-16 Elixiron Immunotherapeutics (Hong Kong) Method of treating vitiligo with interferon-gamma antibody

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204261B1 (en) * 1995-12-20 2001-03-20 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β Converting enzyme inhibitors
US5888511A (en) * 1993-02-26 1999-03-30 Advanced Biotherapy Concepts, Inc. Treatment of autoimmune diseases, including AIDS
CA2297692A1 (en) * 1997-08-18 1999-02-25 Innogenetics N.V. Interferon-gamma-binding molecules for treating septic shock, cachexia, immune diseases and skin disorders

Also Published As

Publication number Publication date
WO2004047864A1 (en) 2004-06-10

Similar Documents

Publication Publication Date Title
AU2003239568A1 (en) Pyrrolotriazinone compounds and their use to treat diseases
AU2003286567A1 (en) Methods for the treatment of skin disorders
AU2003290548A1 (en) Prevention and treatment of synucleinopathic disease
AU2003291992A1 (en) Phenylethanolamine derivatives for the treatment of respiratory diseases
AU2003224788A1 (en) Method for treatment of tissue
AU2003300791A1 (en) Combination therapy for the treatment of pain
AU2003283257A1 (en) Scalp treatment
IL166016A0 (en) Topical treatment of skin diseases
AU2002368219A1 (en) Dermatological preparation for the treatment of skin lesions
AU2003256447A1 (en) Treatment of autoimmune skin diseases
AU2002352566A1 (en) Use of corrinoids in the treatment of skin diseases
AU2003222250A1 (en) Treatment of autoimmune diseases
AU2003213898A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2003270540A1 (en) Treatment of cyclooxygenase-3 mediated diseases and disorders
AU2003297570A1 (en) Treatment of skin diseases
AU1405001A (en) Treatment of diseases
AU2003237742A1 (en) Composition for the treatment of skin diseases and for improving hair growth
HK1071692A (en) Topical treatment of skin diseases
AU2002365654A1 (en) Treatment of diseases via the skin
AU2002364889A1 (en) Methods for diagnosis and treatment of diseases associated with altered expression of nrf2
HK1089982A (en) Treatment of amyloid-and epileptogenesis-associated diseases
AU2003269254A1 (en) Treatment of vascular diseases
AU2003201641A1 (en) Treatment and diagnosis of af4-dependant diseases
AU2003235665A1 (en) Diagnostic and therapeutic uses of topors
AU2003211820A1 (en) NOVEL FUNCTION OF Wnt AND APPLICATION THEREOF TO TREATMENT OF DISEASES

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase